1. Home
  2. DNA vs GBLI Comparison

DNA vs GBLI Comparison

Compare DNA & GBLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$6.94

Market Cap

458.6M

Sector

Health Care

ML Signal

HOLD

Logo Global Indemnity Group LLC (DE)

GBLI

Global Indemnity Group LLC (DE)

HOLD

Current Price

$28.52

Market Cap

444.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNA
GBLI
Founded
2008
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
458.6M
444.5M
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
DNA
GBLI
Price
$6.94
$28.52
Analyst Decision
Hold
Analyst Count
2
0
Target Price
$8.50
N/A
AVG Volume (30 Days)
1.2M
3.2K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
5.13%
EPS Growth
46.49
N/A
EPS
N/A
1.05
Revenue
$170,155,000.00
$450,098,000.00
Revenue This Year
N/A
$14.23
Revenue Next Year
N/A
$9.68
P/E Ratio
N/A
$28.91
Revenue Growth
N/A
2.02
52 Week Low
$5.37
$24.28
52 Week High
$17.58
$30.50

Technical Indicators

Market Signals
Indicator
DNA
GBLI
Relative Strength Index (RSI) 44.55 58.27
Support Level $6.30 $27.56
Resistance Level $7.10 N/A
Average True Range (ATR) 0.47 1.12
MACD 0.03 0.17
Stochastic Oscillator 27.47 80.96

Price Performance

Historical Comparison
DNA
GBLI

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

About GBLI Global Indemnity Group LLC (DE)

Global Indemnity Group LLC is a United States-based holding company with a diversified portfolio of property and casualty insurance-related entities. Along with its subsidiaries, the company operates in the following reportable segments: Agency and Insurance Services, Belmont Insurance Companies - Core (Belmont Core), and Belmont Insurance Companies - Non-Core (Belmont Non-Core). Maximum revenue is generated from the Belmont Core segment, which offers direct insurance and assumed reinsurance products in the E&S (Excess and Surplus) marketplace. The Agency and Insurance Services segment is focused on sourcing, underwriting, and servicing primary and assumed reinsurance business; and specialized insurance service businesses providing technology, AI-enabled marketplace, and claims services.

Share on Social Networks: